The shortage years, and what they taught about interruption
Why the reason for stopping changes what happens afterwards.
The archive — 2026
Page 27 of 34 of this archive, newest first.
Monitoring intervals, and the case against measuring too often
Every additional analyte raises the probability of a flagged result and lowers the average information content of the panel.
A shortage listing ends. 16 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
JEEP names the synthesis and fill sites behind its catalogue
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Singapore declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The online reseller trading as Adamant Research Supply closes after 21 years
A proper account of an operation that existed, and of what closing it cost.
A percentage is not a specification
This piece takes the measurement apart into the decisions it is made of, because each decision moves the answer.
A certificate is a snapshot, and peptides do not stand still
What happens to traceability when bulk material is subdivided, repackaged and relabelled two or three times before sale.
Why "muscle-sparing" is a marketing term and not a measurement
Grading six widely repeated claims against the studies actually behind them.
What a 10% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
A supplier suspends shipping to Singapore after 23 consecutive customs detentions
The route did not close because of a rule about peptides.
The quiet end of Halvard & Pike Apothecary of Portland, Maine
A proper account of an operation that existed, and of what closing it cost.
The quiet end of the consolidator trading as Meridian Freight Partners
A proper account of an operation that existed, and of what closing it cost.
Coming off: what the pharmacology permits
What a slow reduction could plausibly buy, and what it certainly cannot prevent.
REWIND misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Halvard & Pike Apothecary of Portland, Maine closes after 15 years
A proper account of an operation that existed, and of what closing it cost.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
The brainstem does most of the work
A tour of the tissues where the receptor is expressed, and what happens in each.
Who signed this, and what did they undertake by signing it
A manufacturer’s certificate is a self-declaration. An accredited laboratory’s report is a third-party measurement. The trade prints both under one heading.
South Korea declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
A supplier suspends shipping to Norway after 5 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Independent analysis puts a BCH orforglipron lot at 97.2%, against 93.1% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
Percentage of loss, absolute kilograms, and the sleight of hand between them
Both the reassuring reading and the alarming reading are supportable from the same tables. This piece sets out which is which.
What the upper limit of normal for ALT should be, and why it is not
What the renal and hepatic outcome programmes actually measured, and over what duration.
Reading the survodutide titration schedule as a regulatory artefact
What the regulatory dossiers actually contain on dose selection is remarkably thin, and worth knowing before treating the ladder as settled science.
Janoshik result on a Changsha tirzepatide lot lands 0.8 points above the supplier’s stated figure
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The online reseller trading as Adamant Research Supply closes after 3 years
A proper account of an operation that existed, and of what closing it cost.
What the new New Zealand guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.